28 results on '"Sandoli, A."'
Search Results
2. STROKE AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: INCIDENCE AND TEMPORAL TRENDS BETWEEN 2007 AND 2022
- Author
-
Astrid Van Nieuwkerk, Rafael Romaguera, Didier Tchetche, Fabio Sandoli De Brito, Marco Barbanti, Ran Kornowski, Azeem Latib, Augusto D'Onofrio, Flavio Ribichini, Fernando Alfonso, Nicolas Dumonteil, Alexandre Abizaid, samantha sartori, Paola D'Errigo, Giuseppe Tarantini, Katia Orvin, Matteo Pagnesi, EDUARDO PINAR, George D. Dangas, Roxana Mehran, and Ronak Delewi
- Subjects
Cardiology and Cardiovascular Medicine - Published
- 2023
- Full Text
- View/download PDF
3. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
- Author
-
Mangner, Norman, primary, del Val, David, additional, Abdel-Wahab, Mohamed, additional, Crusius, Lisa, additional, Durand, Eric, additional, Ihlemann, Nikolaj, additional, Urena, Marina, additional, Pellegrini, Costanza, additional, Giannini, Francesco, additional, Gasior, Tomasz, additional, Wojakowski, Wojtek, additional, Landt, Martin, additional, Auffret, Vincent, additional, Sinning, Jan Malte, additional, Cheema, Asim N., additional, Nombela-Franco, Luis, additional, Chamandi, Chekrallah, additional, Campelo-Parada, Francisco, additional, Munoz-Garcia, Erika, additional, Herrmann, Howard C., additional, Testa, Luca, additional, Kim, Won-Keun, additional, Castillo, Juan Carlos, additional, Alperi, Alberto, additional, Tchetche, Didier, additional, Bartorelli, Antonio L., additional, Kapadia, Samir, additional, Stortecky, Stefan, additional, Amat-Santos, Ignacio, additional, Wijeysundera, Harindra C., additional, Lisko, John, additional, Gutiérrez-Ibanes, Enrique, additional, Serra, Vicenç, additional, Salido, Luisa, additional, Alkhodair, Abdullah, additional, Livi, Ugolino, additional, Chakravarty, Tarun, additional, Lerakis, Stamatios, additional, Vilalta, Victoria, additional, Regueiro, Ander, additional, Romaguera, Rafael, additional, Kappert, Utz, additional, Barbanti, Marco, additional, Masson, Jean-Bernard, additional, Maes, Frédéric, additional, Fiorina, Claudia, additional, Miceli, Antonio, additional, Kodali, Susheel, additional, Ribeiro, Henrique B., additional, Mangione, Jose Armando, additional, Sandoli de Brito, Fabio, additional, Actis Dato, Guglielmo Mario, additional, Rosato, Francesco, additional, Ferreira, Maria-Cristina, additional, Correia de Lima, Valter, additional, Colafranceschi, Alexandre Siciliano, additional, Abizaid, Alexandre, additional, Marino, Marcos Antonio, additional, Esteves, Vinicius, additional, Andrea, Julio, additional, Godinho, Roger R., additional, Alfonso, Fernando, additional, Eltchaninoff, Helene, additional, Søndergaard, Lars, additional, Himbert, Dominique, additional, Husser, Oliver, additional, Latib, Azeem, additional, Le Breton, Hervé, additional, Servoz, Clement, additional, Pascual, Isaac, additional, Siddiqui, Saif, additional, Olivares, Paolo, additional, Hernandez-Antolin, Rosana, additional, Webb, John G., additional, Sponga, Sandro, additional, Makkar, Raj, additional, Kini, Annapoorna S., additional, Boukhris, Marouane, additional, Gervais, Philippe, additional, Côté, Mélanie, additional, Holzhey, David, additional, Linke, Axel, additional, and Rodés-Cabau, Josep, additional
- Published
- 2022
- Full Text
- View/download PDF
4. Surgical Treatment of Patients With Infective Endocarditis After Transcatheter Aortic Valve Implantation
- Author
-
Norman Mangner, David del Val, Mohamed Abdel-Wahab, Lisa Crusius, Eric Durand, Nikolaj Ihlemann, Marina Urena, Costanza Pellegrini, Francesco Giannini, Tomasz Gasior, Wojtek Wojakowski, Martin Landt, Vincent Auffret, Jan Malte Sinning, Asim N. Cheema, Luis Nombela-Franco, Chekrallah Chamandi, Francisco Campelo-Parada, Erika Munoz-Garcia, Howard C. Herrmann, Luca Testa, Won-Keun Kim, Juan Carlos Castillo, Alberto Alperi, Didier Tchetche, Antonio L. Bartorelli, Samir Kapadia, Stefan Stortecky, Ignacio Amat-Santos, Harindra C. Wijeysundera, John Lisko, Enrique Gutiérrez-Ibanes, Vicenç Serra, Luisa Salido, Abdullah Alkhodair, Ugolino Livi, Tarun Chakravarty, Stamatios Lerakis, Victoria Vilalta, Ander Regueiro, Rafael Romaguera, Utz Kappert, Marco Barbanti, Jean-Bernard Masson, Frédéric Maes, Claudia Fiorina, Antonio Miceli, Susheel Kodali, Henrique B. Ribeiro, Jose Armando Mangione, Fabio Sandoli de Brito, Guglielmo Mario Actis Dato, Francesco Rosato, Maria-Cristina Ferreira, Valter Correia de Lima, Alexandre Siciliano Colafranceschi, Alexandre Abizaid, Marcos Antonio Marino, Vinicius Esteves, Julio Andrea, Roger R. Godinho, Fernando Alfonso, Helene Eltchaninoff, Lars Søndergaard, Dominique Himbert, Oliver Husser, Azeem Latib, Hervé Le Breton, Clement Servoz, Isaac Pascual, Saif Siddiqui, Paolo Olivares, Rosana Hernandez-Antolin, John G. Webb, Sandro Sponga, Raj Makkar, Annapoorna S. Kini, Marouane Boukhris, Philippe Gervais, Mélanie Côté, David Holzhey, Axel Linke, Josep Rodés-Cabau, Technische Universität Dresden = Dresden University of Technology (TU Dresden), Université Laval [Québec] (ULaval), Leipzig University, Endothélium, valvulopathies et insuffisance cardiaque (EnVI), Université de Rouen Normandie (UNIROUEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Pontchaillou [Rennes], Hôpital Européen Georges Pompidou [APHP] (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), CHU Toulouse [Toulouse], Clinique Pasteur [Toulouse], UCL - SSS/IREC/SLUC - Pôle St.-Luc, UCL - (SLuc) Département cardiovasculaire, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)
- Subjects
Aged, 80 and over ,Male ,Prosthesis-Related Infections ,infective endocarditis ,Endocarditis, Bacterial ,Staphylococcal Infections ,Combined Modality Therapy ,antibiotics ,Anti-Bacterial Agents ,TAVI ,Transcatheter Aortic Valve Replacement ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,outcome ,Humans ,cardiac surgery ,Female ,Cardiac Surgical Procedures ,Cardiology and Cardiovascular Medicine ,610 Medicine & health ,Aged - Abstract
BACKGROUND The optimal treatment of patients developing infective endocarditis (IE) after transcatheter aortic valve implantation (TAVI) is uncertain. OBJECTIVES The goal of this study was to investigate the clinical characteristics and outcomes of patients with TAVI-IE treated with cardiac surgery and antibiotics (IE-CS) compared with patients treated with antibiotics alone (IE-AB). METHODS Crude and inverse probability of treatment weighting analyses were applied for the treatment effect of cardiac surgery vs medical therapy on 1-year all-cause mortality in patients with definite TAVI-IE. The study used data from the Infectious Endocarditis after TAVI International Registry. RESULTS Among 584 patients, 111 patients (19%) were treated with IE-CS and 473 patients (81%) with IE-AB. Compared with IE-AB, IE-CS was not associated with a lower in-hospital mortality (HRunadj: 0.85; 95% CI: 0.58-1.25) and 1-year all-cause mortality (HRunadj: 0.88; 95% CI: 0.64-1.22) in the crude cohort. After adjusting for selection and immortal time bias, IE-CS compared with IE-AB was also not associated with lower mortality rates for in-hospital mortality (HRadj: 0.92; 95% CI: 0.80-1.05) and 1-year all-cause mortality (HRadj: 0.95; 95% CI: 0.84-1.07). Results remained similar when patients with and without TAVI prosthesis involvement were analyzed separately. Predictors for in-hospital and 1-year all-cause mortality included logistic EuroSCORE I, Staphylococcus aureus, acute renal failure, persistent bacteremia, and septic shock. CONCLUSIONS In this registry, the majority of patients with TAVI-IE were treated with antibiotics alone. Cardiac surgery was not associated with an improved all-cause in-hospital or 1-year mortality. The high mortality of patients with TAVI-IE was strongly linked to patients' characteristics, pathogen, and IE-related complications. (C) 2022 by the American College of Cardiology Foundation.
- Published
- 2021
- Full Text
- View/download PDF
5. Stroke Complicating Infective Endocarditis After Transcatheter Aortic Valve Replacement
- Author
-
del Val, David, primary, Abdel-Wahab, Mohamed, additional, Mangner, Norman, additional, Durand, Eric, additional, Ihlemann, Nikolaj, additional, Urena, Marina, additional, Pellegrini, Costanza, additional, Giannini, Francesco, additional, Gasior, Tomasz, additional, Wojakowski, Wojtek, additional, Landt, Martin, additional, Auffret, Vincent, additional, Sinning, Jan Malte, additional, Cheema, Asim N., additional, Nombela-Franco, Luis, additional, Chamandi, Chekrallah, additional, Campelo-Parada, Francisco, additional, Munoz-Garcia, Erika, additional, Herrmann, Howard C., additional, Testa, Luca, additional, Won-Keun, Kim, additional, Castillo, Juan Carlos, additional, Alperi, Alberto, additional, Tchetche, Didier, additional, Bartorelli, Antonio L., additional, Kapadia, Samir, additional, Stortecky, Stefan, additional, Amat-Santos, Ignacio, additional, Wijeysundera, Harindra C., additional, Lisko, John, additional, Gutiérrez-Ibanes, Enrique, additional, Serra, Vicenç, additional, Salido, Luisa, additional, Alkhodair, Abdullah, additional, Livi, Ugolino, additional, Chakravarty, Tarun, additional, Lerakis, Stamatios, additional, Vilalta, Victoria, additional, Regueiro, Ander, additional, Romaguera, Rafael, additional, Kappert, Utz, additional, Barbanti, Marco, additional, Masson, Jean-Bernard, additional, Maes, Frédéric, additional, Fiorina, Claudia, additional, Miceli, Antonio, additional, Kodali, Susheel, additional, Ribeiro, Henrique B., additional, Mangione, Jose Armando, additional, Sandoli de Brito Jr, Fabio, additional, Actis Dato, Guglielmo Mario, additional, Rosato, Francesco, additional, Ferreira, Maria-Cristina, additional, Correia de Lima, Valter, additional, Colafranceschi, Alexandre Siciliano, additional, Abizaid, Alexandre, additional, Marino, Marcos Antonio, additional, Esteves, Vinicius, additional, Andrea, Julio, additional, Godinho, Roger R., additional, Alfonso, Fernando, additional, Eltchaninoff, Helene, additional, Søndergaard, Lars, additional, Himbert, Dominique, additional, Husser, Oliver, additional, Latib, Azeem, additional, Le Breton, Hervé, additional, Servoz, Clement, additional, Pascual, Isaac, additional, Siddiqui, Saif, additional, Olivares, Paolo, additional, Hernandez-Antolin, Rosana, additional, Webb, John G., additional, Sponga, Sandro, additional, Makkar, Raj, additional, Kini, Annapoorna S., additional, Boukhris, Marouane, additional, Gervais, Philippe, additional, Linke, Axel, additional, Crusius, Lisa, additional, Holzhey, David, additional, and Rodés-Cabau, Josep, additional
- Published
- 2021
- Full Text
- View/download PDF
6. TCT-296 Atrial Fibrillation in Patients Undergoing Transcatheter Aortic Valve Implantation Is Associated With Increased Mortality
- Author
-
Matteo Pagnesi, Marco Barbanti, Angie Ghattas, Katia Orvin, Mattia Lunardi, Ronak Delewi, Paola D'Errigo, Azeem Latib, Ran Kornowski, Flavio Ribichini, George Dangas, Jan Baan, Augusto D'Onofrio, Juan Francisco Oteo Dominguez, Roxana Mehran, Astrid C. van Nieuwkerk, Nicolas Dumonteil, Didier Tchetche, Giuseppe Tarantini, Samantha Sartori, Alexandre Abizaid, Roberto Blanco, and Fabio Sandoli de Brito
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Internal medicine ,Cardiology ,Medicine ,Atrial fibrillation ,In patient ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease - Published
- 2021
- Full Text
- View/download PDF
7. TCT-159 Balloon-Expandable or Self-Expandable Valves in Valve-in-Valve Transcatheter Aortic Valve Implantation?
- Author
-
Roxana Mehran, Paola D'Errigo, Azeem Latib, Eduard Fernandez-Nofrerias, Angie Ghattas, Marco Barbanti, Ran Kornowski, Giuseppe Tarantini, Didier Tchetche, Matteo Pagnesi, Ronak Delewi, Jan Baan, Katia Orvin, Astrid C. van Nieuwkerk, Nicolas Dumonteil, Samantha Sartori, Mattia Lunardi, George Dangas, Fabio Sandoli de Brito, Vicente Mainar Tello, Augusto D'Onofrio, Alexandre Abizaid, and Flavio Ribichini
- Subjects
medicine.medical_specialty ,Balloon expandable stent ,Transcatheter aortic ,business.industry ,Self expandable ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,Valve in valve ,Surgery - Published
- 2021
- Full Text
- View/download PDF
8. QUANTITATIVE ASSESSMENT OF ACUTE REGURGITATION FOLLOWING TRANSCATHETER AORTIC VALVE IMPLANTATION: A MULTICENTER POOLED ANALYSIS OF 2,258 VALVES
- Author
-
Modolo, Rodrigo G. P, primary, Chang, Chun Chin, additional, Kawashima, Hydeyuki, additional, Ono, Masafumi, additional, Tateishi, Hiroki, additional, Miyazaki, Yosuke, additional, Pighi, Michele, additional, Abdelghani, Mohammad, additional, Wykrzykowska, Joanna, additional, de Winter, Robbert, additional, Ruck, Andreas, additional, Chieffo, Alaide, additional, Yamaji, Kyohei, additional, Brito, Fabio Sandoli, additional, Lemos, Pedro A., additional, Al-Kassou, Baravan, additional, Piazza, Nicolo, additional, Tchetche, Didier, additional, Sinning, Jan-Malte, additional, Abdel-Wahab, Mohamed, additional, Soliman, Osama, additional, Sondergaard, Lars, additional, Onuma, Yoshinobu, additional, Van Mieghem, Nicolas, additional, and Serruys, Patrick, additional
- Published
- 2020
- Full Text
- View/download PDF
9. Predictors and Impact of Myocardial Injury After Transcatheter Aortic Valve Replacement
- Author
-
Asim N. Cheema, César Morís, Raquel del Valle, Fabian Nietlispach, Marina Urena, J H Alonso-Briales, Pilar Jiménez Quevedo, Bruno García del Blanco, Philippe Pibarot, Rogério Sarmento-Leite, Luis Nombela-Franco, Fabio Sandoli de Brito, Pedro A. Lemos, Vicenç Serra, Francesco Maisano, Ignacio J. Amat-Santos, Alexandre Abizaid, Mélanie Côté, Francisco Campelo-Parada, Josep Rodés-Cabau, Rishi Puri, Dimytri Siqueira, Guilherme Bernardi, Hipólito Gutiérrez, Omar Abdul-Jawad Altisent, Eric Dumont, Marc Ruel, Henrique Barbosa Ribeiro, Marco Antonio Perin, Antonio J. Muñoz-García, and Maria Del Trigo
- Subjects
education.field_of_study ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Population ,Retrospective cohort study ,medicine.disease ,Surgery ,Aortic valve replacement ,Valve replacement ,Interquartile range ,Internal medicine ,Aortic valve stenosis ,Cohort ,medicine ,Cardiology ,Biomarker (medicine) ,Cardiology and Cardiovascular Medicine ,education ,business - Abstract
Background Cardiac biomarker release signifying myocardial injury post-transcatheter aortic valve replacement (TAVR) is common, yet its clinical impact within a large TAVR cohort receiving differing types of valve and procedural approaches is unknown. Objectives This study sought to determine the incidence, clinical impact, and factors associated with cardiac biomarker elevation post TAVR. Methods This multicenter study included 1,131 consecutive patients undergoing TAVR with balloon-expandable (58%) or self-expandable (42%) valves. Transfemoral and transapical (TA) approaches were selected in 73.1% and 20.3% of patients, respectively. Creatine kinase-myocardial band (CK-MB) measurements were obtained at baseline and at several time points within the initial 72 h post TAVR. Echocardiography was performed at baseline and at 6- to 12-month follow-up. Results Overall, 66% of the TAVR population demonstrated some degree of myocardial injury as determined by a rise in CK-MB levels (peak value: 1.6-fold [interquartile range (IQR): 0.9 to 2.8-fold]). A TA approach and major procedural complications were independently associated with higher peak of CK-MB levels (p Conclusions Some degree of myocardial injury was detected in two-thirds of patients post TAVR, especially in those undergoing TA-TAVR or presenting with major procedural complications. A greater rise in CK-MB levels associated with greater acute and late mortality, imparting a negative impact on left ventricular function.
- Published
- 2015
- Full Text
- View/download PDF
10. Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve Replacement
- Author
-
Antonio Dager, Juan H. Alonso Briales, Raquel del Valle, Asim N. Cheema, Pedro A. Lemos, Ignacio J. Amat-Santos, Hipólito Gutiérrez, François Philippon, Guilherme Bernardi, Marc Ruel, Fabian Nietlispach, Eric Dumont, Henrique Barbosa Ribeiro, Bruno García del Blanco, Marco Barbanti, Corrado Tamburino, Claire Bouleti, Josep Rodés-Cabau, César Morís, Sebastien Immè, Dominique Himbert, Eulogio García, Vicenç Serra, John G. Webb, Marina Urena, Eric Durand, Luis Nombela-Franco, Hélène Eltchaninoff, Alexandre Abizaid, Dimytri Siqueira, Luis M. Benitez, Rogério Sarmento-Leite, Fabio Sandoli de Brito, Francesco Maisano, Alec Vahanian, Marco Antonio Perin, and Antonio J. Muñoz-García
- Subjects
medicine.medical_specialty ,Ejection fraction ,business.industry ,medicine.medical_treatment ,Atrial fibrillation ,medicine.disease ,Sudden cardiac death ,Blood pressure ,Valve replacement ,Internal medicine ,Heart failure ,medicine.artery ,Cohort ,Pulmonary artery ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Little evidence exists of the burden and predictors of cardiac death after transcatheter aortic valve replacement (TAVR). Objectives The purpose of this study was to assess the incidence and predictors of cardiac death from advanced heart failure (HF) and sudden cardiac death (SCD) in a large patient cohort undergoing TAVR. Methods The study included a total of 3,726 patients who underwent TAVR using balloon (57%) or self-expandable (43%) valves. Causes of death were defined according to the Valve Academic Research Consortium–2. Results At a mean follow-up of 22 ± 18 months, 155 patients had died due to advanced HF (15.2% of total deaths, 46.1% of deaths from cardiac causes) and 57 had died due to SCD (5.6% of deaths, 16.9% of cardiac deaths). Baseline comorbidities (chronic obstructive pulmonary disease, atrial fibrillation, left ventricular ejection fraction ≤40%, lower mean transaortic gradient, pulmonary artery systolic pressure >60 mm Hg; p 160 ms had a greater SCD risk (HR: 4.78, 95% CI: 1.56 to 14.63; p = 0.006). Conclusions Advanced HF and SCD accounted for two-thirds of cardiac deaths in patients after TAVR. Potentially modifiable or treatable factors leading to increased risk of mortality for HF and SCD were identified. Future studies should determine whether targeting these factors decreases the risk of cardiac death.
- Published
- 2015
- Full Text
- View/download PDF
11. TCT-745 Insights Into Sex Differences in Transfemoral Transcatheter Aortic Valve Implantation From 2007–2018: From the CENTER Collaboration, A Global Patient-Level Analysis of 12,381 Patients
- Author
-
Matteo Pagnesi, Wieneke Vlastra, Ran Kornowski, Jaya Chandrasekhar, Augusto D'Onofrio, Jan Baan, Fabio Sandoli de Brito, Raul Moreno, Roxana Mehran, Alberto Berenguer, George Dangas, Giuseppe Tarantini, Paola D'Errigo, Thomas Modine, Katia Orvin, Azeem Latib, Flavio Ribichini, Mattia Lunardi, Didier Tchetche, Samantha Sartori, Jan J. Piek, Ronak Delewi, Flávio Tarasoutchi, Nicolas Dumonteil, Marco Barbanti, and Jan Tijssen
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,business.industry ,medicine ,Center (algebra and category theory) ,Cardiology and Cardiovascular Medicine ,business ,Surgery - Published
- 2019
- Full Text
- View/download PDF
12. Predictive Factors, Management, and Clinical Outcomes of Coronary Obstruction Following Transcatheter Aortic Valve Implantation
- Author
-
Paul T.L. Chiam, Raquel del Valle, Asim N. Cheema, Fernando A. Cura, Josep Rodés-Cabau, Jorge Salgado-Fernández, Corrado Tamburino, Marco Barbanti, Sergio Cánovas, Raj Makkar, Alan Zajarias, Jean Michel Paradis, Antonio Dager, Susheel Kodali, Luis Nombela-Franco, Marina Urena, Sam Radhakrishnan, Eric Larose, Samir R. Kapadia, Henrique Barbosa Ribeiro, Jonathon Leipsic, Marc Ruel, Augusto D. Pichard, Sergio G. Pasian, James L. Velianou, Ganesh Manoharan, E. Murat Tuzcu, Stamatios Lerakis, Rogério Sarmento-Leite, Mauricio G. Cohen, Fabio Sandoli de Brito, Hasan Jilaihawi, Vasilis Babaliaros, Gonzalo Pradas, Eric Dumont, Ignacio J. Amat-Santos, Martin B. Leon, John G. Webb, Hadi Toeg, Peter de Jaegere, Raúl Moreno, Tarun Chakravarty, and Marco Antonio Perin
- Subjects
medicine.medical_specialty ,Percutaneous aortic valve replacement ,business.industry ,medicine.medical_treatment ,Percutaneous coronary intervention ,Surgery ,Left coronary artery ,Coronary occlusion ,Right coronary artery ,medicine.artery ,Internal medicine ,Cohort ,medicine ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Complication ,TIMI - Abstract
Objectives This study sought to evaluate the main baseline and procedural characteristics, management, and clinical outcomes of patients from a large cohort of patients undergoing transcatheter aortic valve implantation (TAVI) who suffered coronary obstruction (CO). Background Very little data exist on CO following TAVI. Methods This multicenter registry included 44 patients who suffered symptomatic CO following TAVI of 6,688 patients (0.66%). Pre-TAVI computed tomography data was available in 28 CO patients and in a control group of 345 patients (comparisons were performed including all patients and a cohort matched 1:1 by age, sex, previous coronary artery bypass graft, transcatheter valve type, and size). Results Baseline and procedural variables associated with CO were older age (p Conclusions Symptomatic CO following TAVI was a rare but life-threatening complication that occurred more frequently in women, in patients receiving a balloon-expandable valve, and in those with a previous surgical bioprosthesis. Lower-lying coronary ostium and shallow sinus of Valsalva were associated anatomic factors, and despite successful treatment, acute and late mortality remained very high, highlighting the importance of anticipating and preventing the occurrence of this complication.
- Published
- 2013
- Full Text
- View/download PDF
13. TCT-317 Propensity Score-Matched Analysis of Operator Radiation Exposure in Percutaneous Coronary Intervention with Radial versus Femoral Approach
- Author
-
Paula Fernanda Gomes, Pedro A. Lemos, Breno Almeida, Adriano Caixeta, Ivanise Gomes, Stella Marinelli Pedrini, Fabio Sandoli de Brito, Marco Tulio Souza, Marcelo Franken, José Mariani, Ana Leoncio, and Carlos M. Campos
- Subjects
medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Percutaneous coronary intervention ,Radiation exposure ,surgical procedures, operative ,Operator (computer programming) ,Femoral access ,Internal medicine ,Propensity score matching ,Conventional PCI ,medicine ,Cardiology ,In patient ,cardiovascular diseases ,Radiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Data regarding operator radiation exposure related to radial versus femoral arterial access in patients undergoing percutaneous coronary intervention (PCI) remain controversial. This study sought to compare operator and patient radiation exposure during PCI with radial versus femoral access. This
- Published
- 2017
- Full Text
- View/download PDF
14. TCT-443 Quantitative assessment of aortic regurgitation in 7 different types of aortic valves after transcatheter aortic valve implantation: a multicenter analysis by an independent core lab not sponsored by the industry
- Author
-
Norihiro Kogame, Rodrigo Modolo, Yoshinobu Onuma, Nicolo Piazza, Zouhair Rahhab, Yosuke Miyazaki, Nicolas M. Van Mieghem, Osama Ibrahim Ibrahim Soliman, Pedro A. Lemos, Patrick W. Serruys, Fabio Sandoli de Brito, Michele Pighi, Mohamed Abdel-Wahab, Mohammad Abdelghani, and Chun Chin Chang
- Subjects
medicine.medical_specialty ,Core (anatomy) ,Transcatheter aortic ,business.industry ,Internal medicine ,Quantitative assessment ,Cardiology ,Medicine ,Regurgitation (circulation) ,Cardiology and Cardiovascular Medicine ,business - Published
- 2018
- Full Text
- View/download PDF
15. TCT-6 The CENTER-Collaboration: Outcomes in patients undergoing transfemoral transcatheter aortic valve implantation with balloon-expandable valves versus self-expandable valves
- Author
-
Ronak Delewi, Nicolas Dumonteil, Antonio J. Muñoz-García, Wieneke Vlastra, Raquel del Valle, Ran Kornowski, Jan Baan, Ramiro Trillo, Jan Tijssen, Matteo Pagnesi, Flavio Ribichini, Marco Barbanti, Samantha Sartori, Jan J. Piek, Katia Orvin, Chiara Fraccaro, Mattia Lunardi, Thomas Modine, Roxana Mehran, Alexandre Abizaid, Paola D'Errigo, Azeem Latib, Augusto D'Onofrio, Didier Tchetche, Jaya Chandrasekhar, and Fabio Sandoli de Brito
- Subjects
medicine.medical_specialty ,Balloon expandable stent ,Transcatheter aortic ,business.industry ,Self expandable ,Medicine ,In patient ,Cardiology and Cardiovascular Medicine ,business ,Surgery - Published
- 2018
- Full Text
- View/download PDF
16. TCT-71 Predictors, incidence and outcomes of patients undergoing transcatheter aortic valve implantation complicated by stroke – From the CENTER-Collaboration
- Author
-
Flavio Ribichini, Wieneke Vlastra, Ran Kornowski, Chiara Fraccaro, Marco Barbanti, Katia Orvin, Roxana Mehran, Nicolas Dumonteil, Matteo Pagnesi, Paola D'Errigo, Jan Tijssen, Azeem Latib, José M. de la Torre Hernández, Jan Baan, Pilar Jiménez-Quevedo, Mattia Lunardi, Thomas Modine, Jan J. Piek, Fabio Sandoli de Brito, Samantha Sartori, Rogério S. Leite, Jaya Chandrasekhar, Ronak Delewi, Augusto D'Onofrio, Rosana Hernández, and Didier Tchetche
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Internal medicine ,Incidence (epidemiology) ,medicine ,Cardiology ,Center (algebra and category theory) ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease ,Stroke - Published
- 2018
- Full Text
- View/download PDF
17. TCT-668 Transcatheter aortic valve implantation in degenerated aortic bioprosthesis: an analysis from the Brazilian TAVI Registry
- Author
-
Rogério Rogério Sarmento-Leite, Julio Andrea, Adriano D. Dourado, José Armando Mangione, Luiz Eduardo Koenig São Thiago, Pedro A. Lemos, Guilherme Bernardi, Fernando Bernardi, Fabio Sandoli de Brito, Valter C. Lima, Dimytri Siqueira, Luiz A. Carvalho, and Paulo R. Prates
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Internal medicine ,Cardiology ,Medicine ,business ,Cardiology and Cardiovascular Medicine - Published
- 2015
- Full Text
- View/download PDF
18. TCT-202 Evaluation of Renal Function Improvement After Transcatheter Aortic Valve Replacement
- Author
-
Marcelo Franken, José Mariani, Carolina Pereira, Breno Almeida, Henrique Barbosa Ribeiro, Adriano Caixeta, Pedro A. Lemos, Flávio Tarasoutchi, Antonio Carlos Bacelar Nunes Filho, Natalia Esteves, Michel V. Lemes da Silva, Rogério Ruscitto Prado, Carlos M. Campos, and Fabio Sandoli de Brito
- Subjects
medicine.medical_specialty ,Valve replacement ,Transcatheter aortic ,business.industry ,Internal medicine ,medicine.medical_treatment ,Cardiology ,Medicine ,Renal function ,Cardiology and Cardiovascular Medicine ,business - Published
- 2017
- Full Text
- View/download PDF
19. PREVALENCE, PREDICTORS AND PROGNOSTIC IMPLICATIONS OF RESIDUAL IMPAIRMENT OF FUNCTIONAL CAPACITY AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
- Author
-
Yosuke Miyazaki, Alexandre Abizaid, Pedro A. Lemos, Rafael Cavalcante, Rogério Sarmento-Leite, José Armando Mangione, Fabio Sandoli de Brito, Mohammad Abdelghani, Patrick W. Serruys, Robbert J. de Winter, Cardiology, Amsterdam Cardiovascular Sciences, ACS - Heart failure & arrhythmias, and ACS - Atherosclerosis & ischemic syndromes
- Subjects
Male ,Quality of life ,medicine.medical_specialty ,Transcatheter aortic ,medicine.medical_treatment ,Pulmonary disease ,030204 cardiovascular system & hematology ,TAVR ,Cardiac mortality ,Residual ,Transcatheter Aortic Valve Replacement ,TAVI ,03 medical and health sciences ,Pulmonary Disease, Chronic Obstructive ,0302 clinical medicine ,Valve replacement ,Risk Factors ,Internal medicine ,Atrial Fibrillation ,Functional capacity ,Prevalence ,Humans ,Medicine ,030212 general & internal medicine ,Registries ,Aged ,Proportional Hazards Models ,Aged, 80 and over ,Heart Failure ,Original Paper ,business.industry ,Atrial fibrillation ,General Medicine ,Aortic Valve Stenosis ,Prognosis ,medicine.disease ,Stenosis ,Treatment Outcome ,Aortic valve stenosis ,Cardiology ,Regression Analysis ,Female ,Functional status ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Patients with degenerative aortic stenosis (AS) referred for transcatheter aortic valve implantation (TAVI) typically have advanced cardiac and vascular adverse remodeling and multiple comorbidities and, therefore, might not recover a normal functional capacity after valve replacement. We sought to investigate the prevalence, the predictors, and the prognostic impact of residual impairment of functional capacity after TAVI. Methods and results Out of 790 patients undergoing TAVI with impaired functional capacity (NYHA II–IV) at baseline, NYHA functional class improved in 592 (86.5%) and remained unchanged/worsened in 92 (13.5%) at follow-up [median (IQR): 419 (208–807) days] after TAVI. Normal functional capacity (NYHA I) was recovered in 65.5% (n = 448) of patients, while the rest had variable degrees of residual impairment. On multivariable regression analysis, atrial fibrillation [odds ratio-OR, 2.08 (1.21–3.58), p = 0.008], low-flow–low-gradient AS [OR, 1.97 (1.09–3.57), p = 0.026], chronic obstructive pulmonary disease [OR, 1.92 (1.19–3.12), p = 0.008], and lower hemoglobin at baseline [OR, 1.11 (1.01–1.21) for each g% decrement, p = 0.036] were independently associated with residual impairment of functional capacity. All-cause and cardiac mortality were significantly higher in those with residual impairment of functional capacity than in those in NYHA I class [hazard ratio-HR: 2.37 (95% CI: 1.51–3.72), p
- Published
- 2017
- Full Text
- View/download PDF
20. HIGH NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL LEVELS PREDICT ENHANCED PERIPROCEDURAL INFLAMMATORY RESPONSE FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN STABLE ISCHEMIC HEART DISEASE PATIENTS
- Author
-
Marcelo Katz, Fabiana Rached, Cibele Larrosa Garzillo, Michael E. Farkouh, Antonio Eduardo Pesaro, Fabio Sandoli de Brito, Roberto Kalil-Filho, Marco Antonio Perin, Teresa Cristina Nascimento, and Carlos V. Serrano
- Subjects
medicine.medical_specialty ,business.industry ,Inflammatory response ,Internal medicine ,medicine.medical_treatment ,Non high density lipoprotein cholesterol ,medicine ,Cardiology ,Percutaneous coronary intervention ,Disease ,Cardiology and Cardiovascular Medicine ,business ,Ischemic heart - Published
- 2017
- Full Text
- View/download PDF
21. TCT-777 Long-term Clinical Outcomes in Nonagenarian Patients Undergoing Transcatheter Aortic Valve Implantation: Multicenter Brazilian Registry
- Author
-
Rogério Rogério Sarmento-Leite, J. Eduardo Sousa, Adriano Caixeta, Dimytri Siqueira, Luiz A. Carvalho, Maria Cristina Ferreira, Pedro A. Lemos, Adriano D. Dourado, Rogério Tadeu Tumelero, Alexandre Siciliano Colafranceschi, José Armando Mangione, Luiz Eduardo Koenig São Thiago, Paulo Caramori, Cesar R. Medeiros, Gabriela Campos Cardoso de Lima, and Fabio Sandoli de Brito
- Subjects
Stenosis ,medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Standard treatment ,cardiovascular system ,otorhinolaryngologic diseases ,Medicine ,macromolecular substances ,business ,medicine.disease ,Cardiology and Cardiovascular Medicine ,Surgery - Abstract
Transcatheter aortic valve implantation (TAVI) has been established as a standard treatment in inoperable and high-risk elderly pts with severe aortic stenosis. However, there is no data thus far assessing the safety and the efficacy of TAVI in pts older than 90 years. We therefore sought to
- Published
- 2013
- Full Text
- View/download PDF
22. DIRECT TRANSCATHETER AORTIC VALVE REPLACEMENT VERSUS IMPLANTATION WITH BALLOON PREDILATATION: INSIGHTS FROM THE BRAZILIAN TAVR REGISTRY
- Author
-
Rogério Sarmento-Leite, Fernando Bernardi, Fabio Sandoli de Brito, Pedro A. Lemos, Eduardo Sousa, Henrique Barbosa Ribeiro, Eberhard Grube, José Armando Mangione, Josep Rodés-Cabau, and Luiz F. Carvalho
- Subjects
Aortic valve ,medicine.medical_specialty ,Transcatheter aortic ,business.industry ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,Balloon ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,Valve replacement ,Internal medicine ,cardiovascular system ,medicine ,Cardiology ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
Direct transcatheter aortic valve replacement (TAVR) is regarded as having potential advantages over TAVR with balloon aortic valve predilatation (BAVP) in reducing procedural complications. However, there is few data to support this approach. The objective of the study was to compare clinical
- Published
- 2016
- Full Text
- View/download PDF
23. PRELIMINARY RESULTS OF THE MULTICENTRIC, DOUBLE-BLINDED, RANDOMIZED, VESTASYNC II TRIAL
- Author
-
Amanda G. M. R. Sousa, Fabio Sandoli de Brito, Breno Almeida, Marcos Perim, Dimytri Siqueira, Fausto Feres, Luiz Fernando Tanajura, Alexandre Abizaid, Ricardo A. Costa, J. Eduardo Sousa, Jose de Ribamar Costa, Andrea Abizaid, and Rodolfo Staico
- Subjects
business.industry ,Double blinded ,Medicine ,business ,Nuclear medicine ,Cardiology and Cardiovascular Medicine - Published
- 2011
- Full Text
- View/download PDF
24. Late Cardiac Death in Patients Undergoing Transcatheter Aortic Valve Replacement
- Author
-
Urena, Marina, primary, Webb, John G., additional, Eltchaninoff, Helene, additional, Muñoz-García, Antonio J., additional, Bouleti, Claire, additional, Tamburino, Corrado, additional, Nombela-Franco, Luis, additional, Nietlispach, Fabian, additional, Moris, Cesar, additional, Ruel, Marc, additional, Dager, Antonio E., additional, Serra, Vicenç, additional, Cheema, Asim N., additional, Amat-Santos, Ignacio J., additional, de Brito, Fabio Sandoli, additional, Lemos, Pedro Alves, additional, Abizaid, Alexandre, additional, Sarmento-Leite, Rogério, additional, Ribeiro, Henrique B., additional, Dumont, Eric, additional, Barbanti, Marco, additional, Durand, Eric, additional, Alonso Briales, Juan H., additional, Himbert, Dominique, additional, Vahanian, Alec, additional, Immè, Sebastien, additional, Garcia, Eulogio, additional, Maisano, Francesco, additional, del Valle, Raquel, additional, Benitez, Luis Miguel, additional, García del Blanco, Bruno, additional, Gutiérrez, Hipólito, additional, Perin, Marco Antonio, additional, Siqueira, Dimytri, additional, Bernardi, Guilherme, additional, Philippon, François, additional, and Rodés-Cabau, Josep, additional
- Published
- 2015
- Full Text
- View/download PDF
25. TCT-689 Percutaneous Closure Of The Left Atrial Appendage: Initial Experience In Latin America
- Author
-
Alejandro Martínez Sepúlveda, Jose F. Condado, Fernando Cura, Leandro Lasave, Carlos A. C. Pedra, Daniel Aguirre, Aníbal Damonte, León Valdivieso, Costantino O. Costantini, and Fabio Sandoli de Brito
- Subjects
Appendage ,medicine.medical_specialty ,Latin Americans ,Percutaneous ,Left atrial ,business.industry ,Internal medicine ,medicine ,Closure (topology) ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Published
- 2013
- Full Text
- View/download PDF
26. TCT-790 Impact of Periprocedural Transesophageal Echocardiography on Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation: Analysis from the Brazilian Registry
- Author
-
Paulo Caramori, Rogério Sarmento-Leite, Fabio Sandoli de Brito, J. Eduardo Sousa, Alexandre Siciliano Colafranceschi, Julio Andrea, José Armando Mangione, Pedro A. Lemos, Valter C. Lima, Dimytri Siqueira, Maria Cristina Ferreira, Luiz A. Carvalho, and Adriano Caixeta
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Internal medicine ,Cardiology ,Medicine ,In patient ,Cardiology and Cardiovascular Medicine ,business ,human activities ,Humanities - Abstract
Adriano Caixeta, J Eduardo Sousa, Luiz Antonio Carvalho, Jose A. Mangione, Rogerio Sarmento-Leite, Alexandre S. Colafranceschi, Pedro Lemos, Paulo Caramori, Julio Andrea, Maria C. Ferreira, Valter Lima, Dimytri Siqueira, Fabio Brito Jr, Hospital Israelita Albert Einstein, Sao Paulo, Brazil, Dante Pazzanese, Sao Paulo, Brazil, Pro-Cardiaco, Rio de Janeiro, Brazil, Beneficencia Portuguesa de Sao Paulo, SAo Paulo, SP, Instituto de Cardiologia, Fundacao Universitaria de Cardiologia, Porto Alegre, Brazil, Instituto Nacional de Cardiologia Laranjeiras, Rio de Janeiro, Brazil, Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil, Hospital Sao Lucas da PUCRS, Porto Alegre, RS, Clinica Sao Vicente, Rio de Janeiro, Brazil, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil, Santa Casa de Misericordia de Porto Alegre, Porto Alegre, Brazil
- Published
- 2013
- Full Text
- View/download PDF
27. EFFECTIVE NEOINTIMAL REDUCTION WITH TWO NOVEL DRUG-ELUTING STENTS COATED WITH BIODEGRADABLE POLYMER – AN INTRAVASCULAR ULTRASOUND ANALYSIS FROM THE PAINT RANDOMIZED TRIAL
- Author
-
Valter C. Lima, Airton Arruda, Pedro A. Lemos, Antonio A.G. Lima, Maurício de Rezende Barbosa, Cesar R. Medeiros, Expedito E. Ribeiro, Marco Antonio Perin, Eulogio E. Martinez, Ludmilla A.R.R. Oliveira, Paulo Caramori, Bruno Moulin, and Fabio Sandoli de Brito
- Subjects
Drug ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,media_common.quotation_subject ,equipment and supplies ,Biodegradable polymer ,law.invention ,Surgery ,chemistry.chemical_compound ,surgical procedures, operative ,Randomized controlled trial ,Paclitaxel ,chemistry ,law ,Sirolimus ,Intravascular ultrasound ,medicine ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business ,medicine.drug ,media_common ,Biomedical engineering - Abstract
Sirolimus and Paclitaxel are well known anti-restenosis agents; they have been tested in different stents with different platforms and polymers. We aim to compare the neointimal inhibition efficacy of two drug eluting stents with identical platforms and biodegradable polymers, but with different
- Published
- 2012
- Full Text
- View/download PDF
28. TCT-647 Predictors and Clinical Impact of Myocardial Injury Following Transcatheter Aortic Valve Replacement: Insights from a Large Multicenter Registry
- Author
-
Hipólito Gutiérrez, Pedro A. Lemos, Omar Abdul-Jawad Altisent, Francesco Maisano, Marc Ruel, Guilherme Bernardi, Dimytri Siqueira, Eric Dumont, Pilar Jiménez-Quevedo, Maria Del Trigo, Henrique Barbosa Ribeiro, Alexandre Abizaid, Rogério Sarmento-Leite, Rishi Puri, Fabio Sandoli de Brito, Vicenç Serra, Luis Nombela-Franco, Raquel del Valle, Marco Antonio Perin, Juan H. Alonso Briales, Josep Rodés-Cabau, Marina Urena, Bruno García del Blanco, Philippe Pibarot, Asim N. Cheema, Ignacio J. Amat-Santos, Francisco Campelo-Parada, César Morís, Fabian Nietlispach, and Antonio J. Muñoz-García
- Subjects
medicine.medical_specialty ,Transcatheter aortic ,Valve replacement ,business.industry ,medicine.medical_treatment ,Internal medicine ,medicine ,Cardiology ,cardiovascular system ,Cardiology and Cardiovascular Medicine ,business - Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.